Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2. | J Gen Virol | 2021 | 34623233 | PubTator, text mining | PubMed |
| MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase. | J Oncol | 2021 | 34603447 | PubTator, text mining | PubMed |
| Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer. | Int J Mol Sci | 2021 | 34576116 | PubTator, text mining | PubMed |
| Plectin in Cancer: From Biomarker to Therapeutic Target. | Cells | 2021 | 34571895 | PubTator, text mining | PubMed |
| Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement. | Sci Rep | 2021 | 34552123 | PubTator, text mining | PubMed |
| Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis. | Front Oncol | 2021 | 34540690 | PubTator, text mining | PubMed |
| Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics. | J Biol Chem | 2021 | 34520756 | PubTator, text mining | PubMed |
| Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. | Cancer Med | 2021 | 34499416 | PubTator, text mining | PubMed |
| Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach. | World J Gastroenterol | 2021 | 34497442 | PubTator, text mining | PubMed |
| Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy. | J Exp Clin Cancer Res | 2021 | 34479614 | PubTator, text mining | PubMed |
| The Optimization and Biological Significance of a 29-Host-Immune-mRNA Panel for the Diagnosis of Acute Infections and Sepsis. | J Pers Med | 2021 | 34442377 | PubTator, text mining | PubMed |
| Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance. | Biomedicines | 2021 | 34440225 | PubTator, text mining | PubMed |
| Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma. | Vet Sci | 2021 | 34437486 | PubTator, text mining | PubMed |
| Targeting AXL in NSCLC. | Lung Cancer (Auckl) | 2021 | 34408519 | PubTator, text mining | PubMed |
| Long noncoding RNA landscapes specific to benign and malignant thyroid neoplasms of distinct histological subtypes. | Sci Rep | 2021 | 34408227 | PubTator, text mining | PubMed |
| Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers. | Orphanet J Rare Dis | 2021 | 34399808 | PubTator, text mining | PubMed |
| SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer. | Mol Cancer Res | 2021 | 34389690 | PubTator, text mining | PubMed |
| Mapping gene and gene pathways associated with coronary artery disease: a CARDIoGRAM exome and multi-ancestry UK biobank analysis. | Sci Rep | 2021 | 34385509 | PubTator, text mining | PubMed |
| Nutrient Acquisition and Attachment Strategies in Basal Lineages: A Tough Nut to Crack in the Evolutionary Puzzle of Apicomplexa. | Microorganisms | 2021 | 34361866 | PubTator, text mining | PubMed |
| Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances. | Nanomaterials (Basel) | 2021 | 34361141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=23